Skip to main content
Erschienen in: Journal of Gastroenterology 12/2019

15.07.2019 | Original Article—Alimentary Tract

Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey

verfasst von: Yoshitaka Murakami, Yuji Nishiwaki, Mari S. Oba, Keiko Asakura, Satoko Ohfuji, Wakaba Fukushima, Yasuo Suzuki, Yosikazu Nakamura

Erschienen in: Journal of Gastroenterology | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Almost a quarter century has passed since the first nationwide survey on ulcerative colitis (UC) and Crohn’s disease (CD) was conducted in Japan. In this study, we used a nationwide survey to estimate the number of patients and prevalence of these diseases in Japan in 2014.

Methods

We conducted a mail-based survey targeting hospitals to estimate the annual numbers of patients with UC and CD in 2014. Respondents were asked to report the numbers of patients who met specific diagnostic criteria for these two conditions. A stratified random sampling method was used, and a total of 3712 departments (internal medicine, surgery, pediatrics, and pediatric surgery) were selected for analysis. The overall and sex-specific annual numbers of UC and CD patients were estimated. The corresponding prevalence rates per 100,000 population were calculated by dividing the number of patients with each disease by the mid-year population of Japan in 2014.

Results

The overall survey response rate was 56.7% (2016 departments). The estimated numbers of patients with UC and CD were 219,685 (95% confidence interval: 183,968–255,403) and 70,700 (56,702–84,699), respectively. The annual prevalence rates of UC and CD per 100,000 population were 172.9 (men: 192.3; women: 154.5) and 55.6 (men: 79.5; women: 33.1), respectively. These numbers are almost tenfold increase in comparing the previous survey (22,300 in UC and 7,400 in CD). The male-to-female ratios were 1.24 for UC and 2.40 for CD, and the UC-to-CD ratio was 3.11.

Conclusions

The prevalence of UC and CD in Japan has risen substantially over the past two decades, and their disease burden requires further examination.
Literatur
1.
Zurück zum Zitat Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol. 2014;28:363–72.CrossRef Ng SC. Epidemiology of inflammatory bowel disease: focus on Asia. Best Pract Res Clin Gastroenterol. 2014;28:363–72.CrossRef
2.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–544.CrossRef Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–544.CrossRef
3.
Zurück zum Zitat Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–78.CrossRef Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–78.CrossRef
7.
Zurück zum Zitat Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30(Suppl 8):1–4.PubMed Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30(Suppl 8):1–4.PubMed
8.
Zurück zum Zitat Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10:29–33.CrossRef Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol. 2000;10:29–33.CrossRef
9.
Zurück zum Zitat Ueno F, Matsui T, Matsumoto T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.CrossRef Ueno F, Matsui T, Matsumoto T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan. J Gastroenterol. 2013;48:31–72.CrossRef
10.
Zurück zum Zitat Matsuoka K, Kobayashi T, Ueno, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53:305–53.CrossRef Matsuoka K, Kobayashi T, Ueno, et al. Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol. 2018;53:305–53.CrossRef
11.
Zurück zum Zitat Hashimoto S, Fukutomi K, Nagai M, et al. A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases [in Japanese]. Nippon Koshu Eisei Zasshi. 1991;38:880–3.PubMed Hashimoto S, Fukutomi K, Nagai M, et al. A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases [in Japanese]. Nippon Koshu Eisei Zasshi. 1991;38:880–3.PubMed
12.
Zurück zum Zitat Ministry of Health, Labour and Welfare. Vital statistics of Japan. Health. Tokyo, Japan: Labour and Welfare Statistics Association; 2014. p. 2016. Ministry of Health, Labour and Welfare. Vital statistics of Japan. Health. Tokyo, Japan: Labour and Welfare Statistics Association; 2014. p. 2016.
13.
Zurück zum Zitat Mano H, Fujiwara S, Takamura K, et al. Congenital limb deficiency in Japan: a cross-sectional nationwide survey on its epidemiology. BMC Musculoskelet Disord. 2018;19:262.CrossRef Mano H, Fujiwara S, Takamura K, et al. Congenital limb deficiency in Japan: a cross-sectional nationwide survey on its epidemiology. BMC Musculoskelet Disord. 2018;19:262.CrossRef
14.
Zurück zum Zitat Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24.CrossRef Fukushima W, Fujioka M, Kubo T, et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res. 2010;468:2715–24.CrossRef
16.
Zurück zum Zitat Moum B, Vatn MH, Ekbom A, et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion. 1995;56:377–81.CrossRef Moum B, Vatn MH, Ekbom A, et al. Incidence of inflammatory bowel disease in southeastern Norway: evaluation of methods after 1 year of registration. Southeastern Norway IBD Study Group of Gastroenterologists. Digestion. 1995;56:377–81.CrossRef
17.
Zurück zum Zitat Ng SC, Tang W, Ching JY, et al; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158–65.CrossRef Ng SC, Tang W, Ching JY, et al; Asia-Pacific Crohn's and Colitis Epidemiologic Study (ACCESS) Study Group. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013;145:158–65.CrossRef
18.
Zurück zum Zitat Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis. 2010;11:76–82.CrossRef Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis. 2010;11:76–82.CrossRef
19.
Zurück zum Zitat Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–9.CrossRef Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986–2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–9.CrossRef
20.
Zurück zum Zitat Asakura K, Nishiwaki Y, Inoue N, et al. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol. 2009;44:659–65.CrossRef Asakura K, Nishiwaki Y, Inoue N, et al. Prevalence of ulcerative colitis and Crohn's disease in Japan. J Gastroenterol. 2009;44:659–65.CrossRef
21.
Zurück zum Zitat Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–82.CrossRef Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–82.CrossRef
22.
Zurück zum Zitat Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–71.CrossRef Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–71.CrossRef
Metadaten
Titel
Estimated prevalence of ulcerative colitis and Crohn’s disease in Japan in 2014: an analysis of a nationwide survey
verfasst von
Yoshitaka Murakami
Yuji Nishiwaki
Mari S. Oba
Keiko Asakura
Satoko Ohfuji
Wakaba Fukushima
Yasuo Suzuki
Yosikazu Nakamura
Publikationsdatum
15.07.2019
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 12/2019
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01603-8

Weitere Artikel der Ausgabe 12/2019

Journal of Gastroenterology 12/2019 Zur Ausgabe

Original Article—Liver, Pancreas, and Biliary Tract

Familial pancreatic cancer risk: a population-based study in Utah

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.